MHRA reaffirms safety of UK childhood vaccines

The Medicines and Healthcare products Regulatory Agency, or MHRA, has restated something health experts have been saying for years: childhood vaccination is one of the safest and most effective ways to protect children from serious infectious disease. The reason this matters now is also familiar. False claims about vaccines and autism keep returning, even though the evidence has been checked repeatedly. If you are reading this as a parent, carer, student or simply someone trying to sort fact from noise, it helps to slow the story down. This is not only about one rumour. It is also about how medical claims are tested, who checks them, and why public bodies keep returning to the same conclusion.

In its statement, the MHRA said large international studies involving millions of children have consistently found no evidence that vaccines cause autism. Among the research it cited is a 2026 US study of 2.56 million children, which found no association between MMR vaccination before age two and childhood autism. It also pointed to a major 2014 meta-analysis published in Vaccine, which reviewed data from more than 1.26 million children in cohort studies and nearly 10,000 children in case-control studies, again finding no association. That matters because good science does not rest on one headline or one dramatic claim. Confidence grows when different studies, using different methods, in different places, keep reaching the same answer. **What this means:** the autism claim has been tested at very large scale, and the evidence has not backed it up.

The next question many people ask is how a vaccine gets approved in the first place. According to the MHRA, vaccines used in the UK go through a strict assessment of safety, quality and efficacy before they are authorised. In everyday language, that means regulators are checking not only whether a vaccine works, but whether it is made to the right standard and whether its benefits clearly outweigh its risks. The routine childhood schedule is not based on guesswork or political instinct. The NHS schedule is informed by recommendations from the Joint Committee on Vaccination and Immunisation, known as the JCVI, which reviews the evidence and advises on which vaccines should be offered and when. That is why the same broad approach is backed by the NHS and major UK public health and paediatric bodies.

Approval is only the first checkpoint. One of the most useful things to understand is that safety monitoring does not stop once a vaccine is already being used in GP surgeries and clinics. The MHRA says it keeps watching through the Yellow Card scheme, large healthcare datasets, international safety evidence and ongoing review by independent scientific experts. **What this means:** the system is built to spot patterns over time, not wait for one dramatic event. If people report suspected side effects, those reports can be compared with wider health data and with evidence from other countries. The MHRA says that if new evidence changed the safety picture, it would act quickly and update guidance for professionals and the public.

Some confusion around vaccines comes from ingredients that people hear about but do not often get explained clearly. The MHRA notes that some vaccines contain adjuvants, which are substances used to strengthen the body's immune response. Aluminium is a commonly used adjuvant in some vaccines, but the agency is clear that it is not used in the MMR vaccine. That point matters because online posts often blur different vaccines together and treat them as if they were all the same. The MHRA also cited a recent large study that did not find evidence of an increased risk of neurodevelopmental disorders, including autism, from early childhood exposure to aluminium-containing vaccines. For us as readers, that is a useful reminder to check whether a scary claim is actually talking about the vaccine in question, and whether the evidence makes proper distinctions.

Behind all of this sits a basic public health point that can get buried when misinformation takes over the conversation. Childhood vaccines are recommended by the NHS, the World Health Organization and health authorities around the world because they help protect children from diseases such as measles, meningitis and whooping cough. These are not distant or harmless illnesses. They can lead to severe complications, hospital treatment and, in some cases, death. So when regulators speak about vaccine safety, they are weighing two realities at once: the known danger of infectious disease and the evidence on vaccine risks. **What this means:** the question is not whether any medical treatment is magical or risk-free. The question is whether the benefits clearly outweigh the risks, and the MHRA says the evidence still shows that they do.

There is also a lesson here about trust. Trust should not mean being told to stop asking questions. It should mean knowing where questions can go. The MHRA says parents and carers should follow NHS vaccination guidance and speak to a healthcare professional if they are unsure about anything. It also asks both the public and healthcare professionals to report suspected side effects through the Yellow Card scheme. For readers of The Common Room, this is a good media literacy test. When you see a frightening claim about vaccines, ask who is making it, what evidence they are using, whether the finding has been repeated in large studies, and what happens when regulators review the full body of evidence rather than one viral post. In this case, the answer from the MHRA is clear: UK childhood vaccines remain safe, and the claim that vaccines cause autism is not supported by the evidence.